Search
for
Sort by
Research 361–390 of 1000+
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Clinical and biological impact of the exposome on the skin
- Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Androgen antagonists in androgen target tissues
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- 25 years of ERβ: a personal journey
- Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis
- Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media
- An Update of Congenital Adrenal Hyperplasia
- The role of diet in the management of psoriasis: a scoping review
- Dermatological manifestations associated with pregnancy
- Changes in Expression and Function of Extrasynaptic GABA<sub>A</sub>Receptors in the Rat Hippocampus during Pregnancy and after Delivery
- Primary cicatricial alopecia
- Adverse Cutaneous Reactions to Antipsychotics
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- Recent advances in oxasteroids chemistry
- ADVANCES IN PSORIASIS THERAPY
- Psychoactive drugs and skin
- Aging Skin: A Window to the Body
- Nonscarring Alopecias
- A comparative analysis of three explanatory models of mental disorder and a preferred focus of explanation
- Cuantificación, caracterización química y biológica del contenido saponósido de Sida cordifolia L. (escobilla)
- Cycle pilaire et alopécie X chez le chien
- Dermatological medications and local therapeutics
- Cutaneous Lupus Erythematosus
- Management of autoimmune associated alopecia areata
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction